Atypical antipsychotics, elderly patients, and mortality risk

Southern Medical Journal

Volumn 100, Issue 10, 2007, Pages 964-965

  Citrome, Leslie ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

BEHAVIOR DISORDER; CAUSE OF DEATH; DEMENTIA; EXTRAPYRAMIDAL SYMPTOM; HEALTH HAZARD; HUMAN; MORTALITY; NOTE; PROGNOSIS; PSYCHOSIS; QT PROLONGATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMENTIA; HUMANS; MORTALITY; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SAFETY; UNITED STATES;

EID: 35148822313     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31815401cb     Document Type: Note

References (11)

1. Ballard C, Waite J. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006;1: CD003476.pub2. DOI: 10.1002/14651858.CD003476.pub2.
2. United States Food and Drug Administration. FDA Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances. April 11, 2005. Available at: http://www.fda.gov/ Cder/drug/advisory/ antipsychotics.htm. Accessed June 3, 2007.
3. Gill SS, Bronskill SE, Normand ST, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007;146:775-786.
4. Citrome L. Relatively speaking, how odd can hazards be? PsychEd Up 2005;1:2-3. Available at: http://www.psy-world.com/Second_ Messenger_Issue10_V1.pdf. Accessed August 20, 2007.
5. Weddington WW. The mortality of delirium: an underappreciated problem? Psychosomatics 1982;23:1232-1235.
6. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-1943.
7. Schneeweiss S, Setoguchi S, Brookhart A, et al. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007;176:627-632.
8. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005;353:2335-2341.
9. Raivio MM, Laurila JV, Strandberg TE, et al. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 2007;15:416-424.
10. Citrome L. Show me the evidence: using number needed to treat. South Med J 2007;100:881-884.
11. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-1312.